Analysis of inhibitor binding in influenza virus neuraminidase

2,3‐didehydro‐2‐deoxy‐N‐acetylneuraminic acid (DANA) is a transition state analog inhibitor of influenza virus neuraminidase (NA). Replacement of the hydroxyl at the C9 position in DANA and 4‐amino‐DANA with an amine group, with the intention of taking advantage of an increased electrostatic interaction with a conserved acidic group in the active site to improve inhibitor binding, significantly reduces the inhibitor activity of both compounds. The three‐dimensional X‐ray structure of the complexes of these ligands and NA was obtained to 1.4 Å resolution and showed that both ligands bind isosterically to DANA. Analysis of the geometry of the ammonium at the C4 position indicates that Glu119 may be neutral when these ligands bind. A computational analysis of the binding energies indicates that the substitution is successful in increasing the energy of interaction; however, the gains that are made are not sufficient to overcome the energy that is required to desolvate that part of the ligand that comes in contact with the protein.

[1]  R C Wade,et al.  'Flu' and structure-based drug design. , 1997, Structure.

[2]  J. McKimm-Breschkin,et al.  Resistance of influenza viruses to neuraminidase inhibitors--a review. , 2000, Antiviral research.

[3]  K. Goa,et al.  Zanamivir , 1999, Drugs.

[4]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[5]  A. Kortt,et al.  A new method for the purification of the influenza A virus neuraminidase. , 1991, Journal of virological methods.

[6]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[7]  Brian J. Smith,et al.  Atomic radii: Incorporation of solvation effects , 1998, J. Comput. Chem..

[8]  B. Jin,et al.  The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. , 1994, Carbohydrate research.

[9]  M. A. Wright,et al.  Synthesis of the potent influenza neuraminidase inhibitor 4-guanidino Neu5Ac2en. X-Ray molecular structure of 5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-D-erythro-L-gluco-nononic acid , 1995 .

[10]  C. Silagy,et al.  Effectiveness and role of zanamivir in the treatment of influenza infection. , 1999, Annals of medicine.

[11]  N R Taylor,et al.  Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. , 1998, Journal of medicinal chemistry.

[12]  G. Air,et al.  Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. , 1995, Journal of medicinal chemistry.

[13]  P. Colman,et al.  The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor , 1992, Proteins.

[14]  I. Miller,et al.  Zanamivir: a review of clinical safety. , 1999, Drug safety.

[15]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[16]  R. Huber,et al.  Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement , 1991 .

[17]  P. Colman,et al.  Three‐dimensional structure of the complex of 4‐guanidino‐Neu5Ac2en and influenza virus neuraminidase , 1995, Protein science : a publication of the Protein Society.

[18]  M. von Itzstein,et al.  Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. , 1994, Journal of medicinal chemistry.

[19]  W G Laver,et al.  Structures of aromatic inhibitors of influenza virus neuraminidase. , 1995, Biochemistry.

[20]  Brian J. Smith.  A CONFORMATIONAL STUDY OF 2-OXANOL : INSIGHT INTO THE ROLE OF RING DISTORTION ON ENZYME-CATALYZED GLYCOSIDIC BOND CLEAVAGE , 1997 .

[21]  G. Air,et al.  A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase , 1995, Proteins.

[22]  P. Colman,et al.  Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en. , 1995, Virology.

[23]  B. Honig,et al.  Calculation of the total electrostatic energy of a macromolecular system: Solvation energies, binding energies, and conformational analysis , 1988, Proteins.

[24]  G. Air,et al.  Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding , 1995, Journal of virology.

[25]  Mark von Itzstein,et al.  A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase , 1996, J. Comput. Aided Mol. Des..

[26]  G. Air,et al.  Influenza virus neuraminidase with hemagglutinin activity. , 1984, Virology.

[27]  A. Vasella,et al.  Carbocyclic Analogues of N-Acetyl-2,3-didehydro-2-deoxy-D-neuraminic Acid (Neu5Ac2en, DANA): Synthesis and Inhibition of Viral and Bacterial Neuraminidases. , 1998, Angewandte Chemie.

[28]  B. Honig,et al.  A rapid finite difference algorithm, utilizing successive over‐relaxation to solve the Poisson–Boltzmann equation , 1991 .

[29]  G. Air,et al.  Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. , 1999, Journal of medicinal chemistry.

[30]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[31]  Paul W Smith,et al.  Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guanidino-Neu5Ac2en (GG167) with modified 5-substituents , 1996 .

[32]  W G Laver,et al.  Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. , 1997, Journal of molecular biology.

[33]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[34]  A Merritt,et al.  Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides. , 1998, Journal of medicinal chemistry.

[35]  C. Breneman,et al.  Determining atom‐centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysis , 1990 .

[36]  S Cusack,et al.  Influenza B virus neuraminidase can synthesize its own inhibitor. , 1993, Structure.

[37]  Xiaowu Chen,et al.  Neuraminidase Inhibitors as Anti-Influenza Virus Agents , 1999, Antiviral chemistry & chemotherapy.

[38]  J. Varghese,et al.  Development of neuraminidase inhibitors as anti‐influenza virus drugs , 1999 .

[39]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[40]  R. Storer,et al.  Synthesis of 6-, 7- and 8-carbon sugar analogues of potent anti-influenza 2,3-didehydro-2,3-dideoxy-N-acetylneuraminic acid derivatives , 1995 .

[41]  G. Air,et al.  Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. , 1995, Journal of medicinal chemistry.

[42]  Paul W Smith,et al.  Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. , 1998, Structure.

[43]  Paul W Smith,et al.  Synthesis and influenza virus sialidase inhibitory activity of the 5-desacetamido analogue of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid (GG167) , 1995 .

[44]  M. Lawrence,et al.  CONSCRIPT: a program for generating electron density isosurfaces for presentation in protein crystallography , 2000 .

[45]  W G Laver,et al.  Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. , 1998, Journal of medicinal chemistry.

[46]  Brian J. Smith.  Solvation parameters for amino acids , 1999, J. Comput. Chem..

[47]  Taylor Nr,et al.  Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. , 1994 .